Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The International Journal of Biological Markers|January 1, 1995
The clinical value of CEA and CA 15-3 in breast cancer managementE C Coveney, J G Geraghty, F Sherry, et al.
The American Journal of Physiology|November 1, 1992
A study of regional distribution of renal blood flow using quantitative autoradiographyJ G Geraghty, M Nsubuga, W J Angerson, et al.
Clinical Radiology|March 16, 2002
Predicting invasion in mammographically detected microcalcificationM J Bagnall, A J Evans, A R Wilson, et al.
Surgery|February 8, 2000
Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidanceR Gennari, M Bartolomei, A Testori, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2015
Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancerF Aloraifi, M Alshehhi, T McDevitt, et al.
Melanoma Research|February 8, 2000
Sentinel node localization in primary melanoma: learning curve and resultsA Testori, M Bartolomei, C Grana, et al.
The British Journal of Radiology|March 7, 2000
A comparison of 14 and 12 gauge needles for core biopsy of suspicious mammographic calcificationA J Evans, J P Whitlock, H C Burrell, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison studyR D Macmillan, D Barbera, D J Hadjiminas, et al.
Lancet (London, England)|June 28, 1997
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesU Veronesi, G Paganelli, V Galimberti, et al.
Breast Cancer Research and Treatment|April 9, 2021
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in IrelandL M McSorley, M Tharmabala, F Al Rahbi, et al.
Pageof 5